Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being …
Biotechnology
US, Boulder [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Enliven Therapeutics, Inc. (ELVN) to it's peer group.
Peer Group
MLTX GPCR AVTE CGEM KRON CMPX GOSS PMVP ELYM CELC INBX IMRX NVCT MACK REPL LYRA THRX
Compare Together
Loading...